XML 134 R51.htm IDEA: XBRL DOCUMENT v3.20.4
Deferred tax assets and liabilities (Tables)
12 Months Ended
Dec. 31, 2020
Disclosure of Deferred Tax Assets and Liabilities [abstract]  
Schedule of Deferred Tax Assets and Liabilities


(USD millions)


Property,

plant and

equipment




Intangible

assets
Pensions and

other benefit

obligations

of associates






Inventories


Tax loss

carry-

forwards


Other assets,

provisions

and accruals






Total
Gross deferred tax assets at January 1, 2020
108
1 469
1 078
2 446
255
2 596
7 952
Gross deferred tax liabilities at January 1, 2020
– 390
– 3 610
– 291
– 287
– 7
– 1 325
– 5 910
Net deferred tax balance at January 1, 2020
– 282
– 2 141
787
2 159
248
1 271
2 042
At January 1, 2020
– 282
– 2 141
787
2 159
248
1 271
2 042
Credited/(charged) to income
89
110
– 25
212
– 164
71
293
Charged to equity
9
9
Charged to other comprehensive income
– 3
– 36
– 39
Impact of acquisitions of businesses
5
– 1 945
– 3
408
34
– 1 501
Other movements
– 53
58
38
– 25
5
– 35
– 12
Net deferred tax balance at December 31, 2020
– 241
– 3 918
797
2 343
497
1 314
792
Gross deferred tax assets at December 31, 2020
189
1 351
1 137
2 502
507
2 658
8 344
Gross deferred tax liabilities at December 31, 2020
– 430
– 5 269
– 340
– 159
– 10
– 1 344
– 7 552
Net deferred tax balance at December 31, 2020
– 241
– 3 918
797
2 343
497
1 314
792
After offsetting the following amount of deferred tax assets and liabilities within the same tax jurisdiction, the balance amounts to:
130
Deferred tax assets at December 31, 2020
8 214
Deferred tax liabilities at December 31, 2020
– 7 422
Net deferred tax balance at December 31, 2020
792
Gross deferred tax assets at January 1, 2019
191
1 233
1 188
3 722
273
2 175
8 782
Gross deferred tax liabilities at January 1, 2019
– 622
– 5 384
– 273
– 474
– 805
– 7 558
Net deferred tax balance at January 1, 2019
– 431
– 4 151
915
3 248
273
1 370
1 224
At January 1, 2019
– 431
– 4 151
915
3 248
273
1 370
1 224
Net deferred tax balance related to discontinued operations  1
82
1 403
– 123
– 248
– 39
– 217
858
Credited/(charged) to income
74
605
308
– 818
– 113
298
354
Charged to equity
8
75
– 166
– 83
Charged to other comprehensive income
– 313
24
– 289
Impact of acquisitions of businesses
3
– 45
21
– 26
– 47
Other movements
– 10
39
– 23
31
– 12
25
Net deferred tax balance at December 31, 2019
– 282
– 2 141
787
2 159
248
1 271
2 042
Gross deferred tax assets at December 31, 2019
108
1 469
1 078
2 446
255
2 596
7 952
Gross deferred tax liabilities at December 31, 2019
– 390
– 3 610
– 291
– 287
– 7
– 1 325
– 5 910
Net deferred tax balance at December 31, 2019
– 282
– 2 141
787
2 159
248
1 271
2 042
After offsetting the following amount of deferred tax assets and liabilities within the same tax jurisdiction, the balance amounts to:
43
Deferred tax assets at December 31, 2019
7 909
Deferred tax liabilities at December 31, 2019
– 5 867
Net deferred tax balance at December 31, 2019
2 042
 
 1  Notes 1, 2 and 30 provide information related to discontinued operations.
 
Deferred tax assets/liabilities, expected to have impact on current taxes payable
(USD billions)
2020
2019
Expected to have an impact on current tax payable after more than 12 months
– Deferred tax assets
4.5
4.3
– Deferred tax liabilities
7.0
5.2
Temporary differences on which no deferred tax assets have been provided
(USD billions)
2020
2019
Investments in subsidiaries
5
3
Goodwill from acquisitions
– 27
– 24
Gross value of tax-loss carry-forwards
(USD millions)
Not capitalized
Capitalized
2020 total
One year
20
20
Two years
1
5
6
Three years
2
6
8
Four years
23
23
Five years
11
40
51
More than five years  1
3 400
2 291
5 691
Not subject to expiry
323
683
1 006
Total
3 780
3 025
6 805
 1  Not capitalized more than five years includes USD 3.2 billion attributable to US state tax-loss carry-forwards, of which USD 1.6 billion relates to The Medicines Company, which was acquired in 2020 (see Note 2).
(USD millions)
Not capitalized
Capitalized
2019 total
One year
14
0
14
Two years
28
0
28
Three years
28
6
34
Four years
16
46
62
Five years
127
37
164
More than five years
125
2 214
2 339
Not subject to expiry
310
35
345
Total
648
2 338
2 986
(USD millions)
2020
2019
2018
Tax losses carried forward

that expired


14


9


8
CH Corporate tax rate, impact on the revaluation of deferred assets and liabilities and current income tax liabilities


(USD millions)
Income

statement

continuing

operations






Equity






Total
Deferred tax asset

and liability revaluation






Items previously recognized

in consolidated income statement


234




234
Items previously recognized in other comprehensive income  1
– 358
– 358
Total revaluation of deferred tax assets and liabilities
234
– 358
– 124
 1  Related to post-employment benefits